PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 106 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q2 2017. The put-call ratio across all filers is 112.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $18,168,000 | -75.1% | 2,455,114 | -81.8% | 1.34% | -66.1% |
| Q3 2018 | $73,105,000 | +63.7% | 13,512,958 | +7.5% | 3.94% | +36.7% |
| Q2 2018 | $44,645,000 | +73.2% | 12,576,002 | 0.0% | 2.88% | +22.2% |
| Q1 2018 | $25,781,000 | +38.2% | 12,576,002 | +78.0% | 2.36% | +39.8% |
| Q4 2017 | $18,654,000 | -48.5% | 7,065,920 | +2.4% | 1.68% | -57.9% |
| Q3 2017 | $36,232,000 | +165.6% | 6,901,428 | +80.1% | 4.01% | +149.2% |
| Q2 2017 | $13,644,000 | +74.0% | 3,832,713 | +243.9% | 1.61% | +44.9% |
| Q2 2016 | $7,840,000 | -79.6% | 1,114,448 | -75.3% | 1.11% | -80.9% |
| Q1 2016 | $38,399,000 | -46.8% | 4,517,517 | -17.8% | 5.81% | -40.0% |
| Q4 2015 | $72,198,000 | +215.2% | 5,498,712 | -12.1% | 9.68% | +200.5% |
| Q3 2015 | $22,904,000 | -26.3% | 6,257,861 | +15.9% | 3.22% | +3.2% |
| Q2 2015 | $31,097,000 | +165.9% | 5,398,861 | +169.5% | 3.12% | +193.3% |
| Q1 2015 | $11,697,000 | – | 2,002,971 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WATER ISLAND CAPITAL LLC | 4,718,964 | $24,255,000 | 1.69% |
| HighVista Strategies LLC | 378,479 | $1,945,000 | 1.48% |
| Exane Asset Management | 198,743 | $1,021,539,000 | 1.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,110,666 | $5,709,000 | 1.07% |
| BOURNE LENT ASSET MANAGEMENT INC | 441,650 | $2,270,000 | 1.07% |
| Versor Investments LP | 3,148,691 | $16,184,000 | 0.82% |
| Magnetar Financial LLC | 6,919,655 | $35,567,000 | 0.74% |
| AQR Arbitrage LLC | 6,953,621 | $35,742,000 | 0.60% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 915,124 | $4,704,000 | 0.54% |
| Bellevue Group AG | 5,734,309 | $29,474,000 | 0.47% |